Janel Corp
Janel Corp is a U.S.-based holding company with operating subsidiaries in logistics, life sciences, and manufacturing. It creates value by allocating capital across these businesses, supporting organic growth, and acquiring companies that fit its portfolio and management style.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueNon-asset-based cargo transportation management, including forwarding, brokerage, warehousing, trucking, and accessorial charges.
Protein-related research and diagnostic reagents sold to scientific and clinical customers.
Industrial/manufacturing activities and related products within the portfolio.
Products
Reported · share of revenue- Logistics88.6 %
- Life Sciences and Manufacturing11.4 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Janel serves a broad logistics customer base that uses freight forwarding, customs brokerage, and warehousing to move goods efficiently across modes and borders. Its life sciences customers include academic, diagnostic, and pharmaceutical research users that buy reagents for research and testing workflows. The company also sells to customers that value its scientific expertise and may re-label products, while logistics customers range from diversified shippers to businesses needing flexible, non-asset-based transport solutions.
Businesses shipping freight domestically and internationally that buy forwarding, brokerage, warehousing, and trucking services to reduce complexity and transit time.
Universities and research labs buying protein-related reagents and tools for life science research.
Clinical and pharma buyers using reagents and scientific products for testing, development, and research workflows.
Customers that use Janel's scientific expertise and production capabilities to source products under their own brand.
Strategy
Janel's strategy centers on disciplined capital allocation, organic growth, and acquisitions that add stable earnings power. Management also emphasizes operational improvement, talent retention, and product innovation, especially in life sciences, to strengthen profitability and expand the portfolio over time.
Janel expects growth from buying businesses within existing segments or entering new ones.
Better operating design and processes can lift profitability and free capital for growth.
New products can broaden the research toolkit and deepen customer relationships.
Geography
Janel is headquartered in New York and operates primarily in the United States, where it employed all 353 full-time employees as of fiscal 2025. Its logistics segment also serves international trade lanes through a network of independent agents in many trading countries, so a meaningful part of the business is exposed to cross-border freight flows. The company does not disclose a country-level revenue split in the provided excerpts, but its logistics activity is clearly global in scope.
Risks
Janel's growth model depends heavily on acquisitions, so deal sourcing, integration, and valuation discipline are central risks. Its logistics business is exposed to trade disruption, cybersecurity, and third-party system failures, while the life sciences business faces competitive pressure and product-development execution risk. Because the company uses a holding-company structure, performance also depends on how well capital is allocated across subsidiaries and whether acquired earnings prove durable.
- Geopolitical and trade disruptionImpact: HighLikelihood: High
Logistics volumes and routing can be affected by war, terrorism, and border/security changes.
Exposure: Most relevant to freight forwarding and cross-border shipments.
- Acquisition execution and valuation riskImpact: HighLikelihood: Medium
Growth depends on buying businesses at reasonable prices and integrating them successfully.
Exposure: Could reduce profitability if targets underperform or synergies do not materialize.
- Cybersecurity and IT systems riskImpact: HighLikelihood: Medium
The company relies on internal and third-party systems to manage shipments and sensitive data.
Exposure - Third-party provider dependenceImpact: MediumLikelihood: High
Janel is non-asset-based and relies on carriers, agents, and vendors to execute shipments.
Exposure: Service quality and margins depend on external partners.
Accounting
Judgemental itemsPurchased customer relationships and other intangibles create amortization that reduces reported earnings.
Impact: Can materially affect operating income and net income after acquisitions.
Management excludes recent acquisitions to show underlying performance.
Impact: Important for comparing periods, especially after deal activity.
This measure excludes items not in GAAP and may present a different profitability trend.
Impact: Can influence investor perception of core operating performance.
Similar listed companies
Publicly listed companies with a comparable business focus.
Jabil Inc
JBL · Printed Circuit Boards
Jabil designs, manufactures, and manages supply chains for customer-specific products across electronics-heavy and regulated end markets.
Jayud Global Logistics Ltd
JYD · Arrangement of Transportation of Freight & Cargo
Jayud Global Logistics Ltd is a freight forwarding and logistics company based in Shenzhen, China and organized as a Cayman Islands public company listed on Nasdaq.
Forward Air Corporation
FWRD · Arrangement of Transportation of Freight & Cargo
Forward Air Corp is an asset-light transportation and logistics company that moves freight through expedited ground transport, air and ocean forwarding, intermodal drayage, and contract logistics.
Gilead Sciences, Inc
GILD · Biological Products, (No Diagnostic Substances)
Gilead Sciences is a U.S.-based biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious diseases.
Nautilus Biotechnology, Inc.
NAUT · Laboratory Analytical Instruments
DLH Holdings Corp.
DLHC · Services-Help Supply Services
Last updated: 24/09/2026